VC Insider Notice: Merrill Lynch Sale of 4,350 Shares on 08/22/2025

Rhea-AI Filing Summary

Visteon Corporation (VC) filed a Form 144 reporting a proposed sale of 4,350 shares of common stock through Merrill Lynch (100 Campus Drive, Florham Park, NJ) with an approximate aggregate market value of $522,482.00. The filing lists 27,276,339 shares outstanding and an approximate sale date of 08/22/2025 on the NYSE. The securities were acquired in open-market purchases: 1,150 shares on 12/04/2012 and 3,200 shares on 06/13/2014, with full payment made at acquisition. The filer reports no securities sold in the past three months and includes the standard representation that the signer is not aware of undisclosed material adverse information.

Positive

• Complete disclosure of broker, share counts, acquisition dates, and payment method in accordance with Rule 144 requirements
• Attestation included that the filer is not aware of undisclosed material adverse information
• No sales in prior three months reported, providing clear recent trading history

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 4,350 shares valued at $522,482; disclosure aligns with Rule 144 requirements.

The Form 144 documents a proposed sale by a person associated with Visteon of 4,350 common shares via Merrill Lynch with an aggregate market value of $522,482 and an intended sale date of 08/22/2025. Acquisition history is provided for each lot, both purchased in the open market in 2012 and 2014 with full payment at purchase. The filer states there were no sales in the prior three months and attests to lack of undisclosed material adverse information. Based solely on the filing content, this is a standard Rule 144 notification without additional financial details or indicators of material corporate events.

Compliance/Risk Analyst

TL;DR: Filing appears complete for Rule 144 notice; includes broker, acquisition details, and required attestation.

The submission names the broker, provides exact share counts, acquisition dates and payment nature, and declares no recent sales in the prior three months. The filer also includes the required attestation regarding material adverse information. From a compliance perspective, the form contains the necessary elements for a Rule 144 notice and presents no express qualifications or omitted fields in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Merrill Lynch 100 Campus Drive Florham Park NJ 07932	4350	522482.00	27276339	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	12/04/2012	open market	open market			1150	12/04/2012	open market
common	06/13/2014	open market	open market			3200	06/13/2014	open market

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Visteon (VC) report in this Form 144?

The filing reports a proposed sale of 4,350 common shares with an aggregate market value of $522,482.00, to be sold on 08/22/2025 on the NYSE.

Who is the broker handling the proposed sale for VC?

The broker listed is Merrill Lynch with address 100 Campus Drive, Florham Park, NJ.

What were the acquisition dates and amounts for the shares being sold?

The shares were acquired in the open market: 1,150 shares on 12/04/2012 and 3,200 shares on 06/13/2014.

Has the filer sold any Visteon securities in the past three months?

The filing states Nothing to Report under securities sold during the past three months.

What representation does the filer make about material information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.